SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

VolitionRx Limited (VNRX) News

Follow VolitionRx Limited (VNRX) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 16 public stories across 13 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol VNRX Asset equity Sector Markets 90 days 10 Last 0.1845 Updated Oct 27, 2026, 12:20 PM UTC Open live news feed Open VNRX chart & news
M VolitionRx Announces $500,000 Cash Prepayment on Convertible Note VolitionRx Limited announced a $500,000 partial prepayment of a convertible note in cash. EQUITY | Oct 27, 2026, 12:20 PM UTC L VNRX - VolitionRx Shares Further Details and Video of the DETECSEPS Program Launch in France VNRX - VolitionRx Shares Further Details and Video of the DETECSEPS Program Launch in France EQUITY | Sep 17, 2026, 01:18 PM UTC L VNRX - VolitionRx Participates in Launch of DETECSEPS Program in France VNRX - VolitionRx Participates in Launch of DETECSEPS Program in France NEWS | Sep 17, 2026, 12:17 PM UTC L VolitionRx pre-pays $422k of 2025 convertible note; $2.04M Lind note remains outstanding VolitionRx prepaid approximately $422,000 to retire its 2025 senior secured convertible note, eliminating that instrument and reducing potential equity overhang.Key Highlights:Original SEC Filing: VOLITIONRX LTD [ VNRX ] REGULATION | Sep 14, 2026, 09:15 PM UTC L VNRX: Strong IP, new products, and global partnerships drive licensing and clinical adoption in 2026 Recent milestones include a $5M milestone opportunity, new product launches, and expansion into non-sepsis disease areas. The company leverages a strong IP portfolio, asset-light model, and global partnerships, with mult EQUITY | Sep 10, 2026, 12:35 PM UTC L VNRX - Volition Presents Early Stage I Solid Cancer Detection at the ESMO MAP Conference VNRX - Volition Presents Early Stage I Solid Cancer Detection at the ESMO MAP Conference EQUITY | Sep 10, 2026, 12:17 PM UTC M Lagoda-backed holder files Schedule 13D after 7.4% VolitionRx stake Fatima Dickey, via Lagoda Investment Management, disclosed a 7.4% stake in VolitionRx. The holder switched from a passive Schedule 13G to an active Schedule 13D filed September 4, 2026. EQUITY | Sep 04, 2026, 09:37 PM UTC L Volitionrx files preliminary prospectus for 10,006,360 common shares Volitionrx filed a preliminary prospectus for 10,006,360 shares of common stock to be offered by a selling stockholder. REGULATION | Aug 28, 2026, 08:33 PM UTC L VNRX - VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution Across $27+ Billion Total Addressable Markets - Click For Releas VNRX - VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution Across $27+ Billion Total Addressable Markets EQUITY | Aug 26, 2026, 01:17 PM UTC L Volition announces clinical validation for Nu.Q NETs biomarker in sepsis Volition (VNRX) said clinical validation of its Nu.Q NETs biomarker in sepsis has been announced. EQUITY | Aug 26, 2026, 12:17 PM UTC L VolitionRx reports Q2 2026 results and provides business update VolitionRx Limited announces its second quarter 2026 financial results and a business update for VNRX, with no additional figures provided in the feed. EARNINGS | Aug 13, 2026, 08:10 PM UTC L VNRX - Volition Demonstrates Utility of Rapid, Point-of-Care Finger-Prick Test in Sepsis Patients VNRX - Volition Demonstrates Utility of Rapid, Point-of-Care Finger-Prick Test in Sepsis Patients EQUITY | Aug 12, 2026, 12:17 PM UTC L VNRX - VolitionRx Limited Schedules Second Quarter 2026 Earnings Conference Call and Business Update VNRX - VolitionRx Limited Schedules Second Quarter 2026 Earnings Conference Call and Business Update EARNINGS | Aug 11, 2026, 08:10 PM UTC M Volition Publishes Paper On Capture-Seq Liquid Biopsy Volition publishes peer-reviewed paper on new liquid biopsy tech EQUITY | Aug 05, 2026, 12:48 PM UTC H Volition Advances Nu.Q Platform Volition advances platform towards commercialization EQUITY | Jul 30, 2026, 12:18 PM UTC L VolitionRx registers to sell 3.31M shares of common stock for holders VolitionRx registers to sell 3.31M shares of common stock for holders EQUITY | Jul 10, 2026, 09:31 PM UTC